Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2011-08-09
2011-08-09
Angell, Jon E (Department: 1635)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C514S04400A
Reexamination Certificate
active
07994150
ABSTRACT:
The present invention relates to the identification of microRNAs that regulate smooth muscle cell proliferation and differentiation, including the miR-143/miR-145 cluster. Methods of treating restenosis and neointima formation by increasing expression of miR-143 and/or miR-145 are disclosed. The present invention also relates to the identification of two microRNAs, miR-486 and miR-422a, that regulate cell survival in the heart. Methods of treating or preventing cardiac hypertrophy, heart failure, or myocardial infarction by increasing expression of miR-486 and/or miR-422a in heart tissue are also disclosed.
REFERENCES:
patent: 2009/0232893 (2009-09-01), Bader et al.
patent: WO 03/029459 (2003-04-01), None
patent: WO 2009/137807 (2009-11-01), None
International Search Report and Written Opinion based on International Application PCT/US2009/034887 (Nov. 25, 2009).
Olson Eric
Small Eric
Xin Mei
Angell Jon E
Board of Regents , The University of Texas System
Cooley LLP
LandOfFree
Micro-RNAs that modulate smooth muscle proliferation and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Micro-RNAs that modulate smooth muscle proliferation and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Micro-RNAs that modulate smooth muscle proliferation and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2679192